Paper Details

  1. Home
  2. Paper Details

Real-World Analysis Affirms the High Persistence and Adherence Observed with Diroximel Fumarate in Patients with Multiple Sclerosis.

Author: BožinIvan, EnglandSarah M, LagerBrittney, LewinJames B, LisenoJacob, MendozaJason P, ShankarSai L

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

This study examines the real-world persistence and adherence to diroximel fumarate (DRF) in patients with multiple sclerosis (MS). It aims to provide insights into real-world use of DRF, which has demonstrated fewer gastrointestinal side effects compared to dimethyl fumarate.
Paper Details　
Original Abstract of the Article :
Adherence to disease-modifying therapies is key for achieving optimal outcomes in multiple sclerosis (MS). Diroximel fumarate (DRF) is an oral fumarate approved for treatment of relapsing forms of MS. It has the same pharmacologically active metabolite as dimethyl fumarate (DMF) and similar efficacy...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9837354/

データ提供：米国国立医学図書館（NLM）

Diroximel Fumarate for Multiple Sclerosis: A Steady Caravan in the Desert

This research examines the real-world effectiveness of diroximel fumarate (DRF) in managing multiple sclerosis (MS). It’s a journey through the challenging desert of MS, where DRF serves as a steady caravan, providing consistent support and relief. The study focuses on the crucial aspect of adherence, the key to achieving optimal outcomes in treating this chronic disease. The researchers investigated the persistence and adherence to DRF in real-world settings, providing valuable insights into its long-term effectiveness.

A Reliable Caravan: Diroximel Fumarate in the Desert of MS

The study found that DRF demonstrated high levels of persistence and adherence in real-world settings, suggesting its effectiveness in managing MS over time. It’s like a reliable caravan, steadily traversing the vast desert of MS, providing consistent support and relief. This research underscores the importance of patient engagement and adherence to treatment plans in achieving long-term benefits.

Navigating the Desert of Adherence: A Collaborative Journey

This research highlights the importance of collaboration between healthcare providers and patients to ensure adherence to treatment plans. It’s like a camel caravan navigating a vast desert, where the success of the journey depends on teamwork and a shared commitment to reaching the destination. By working together, we can help patients manage their MS effectively and improve their quality of life.

Dr. Camel's Conclusion

This research offers valuable insights into the real-world effectiveness of diroximel fumarate (DRF) in managing multiple sclerosis (MS). It's like a steady caravan, traversing the challenging desert of MS, providing consistent support and relief. This research underscores the importance of adherence to treatment plans in achieving optimal outcomes in managing this chronic disease.

Date :
  1. Date Completed n.d.
  2. Date Revised 2023-11-21
Further Info :

Pubmed ID

36334241

DOI: Digital Object Identifier

PMC9837354

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.